Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

APC Panel Meeting News In Brief

This article was originally published in The Gray Sheet

Executive Summary

High-dose rate brachytherapy: CMS should evaluate ways to improve data methodology for APC 313 (high-dose rate brachytherapy) for the 2005 hospital outpatient prospective payment system update, the Advisory Panel on Ambulatory Patient Classification Groups suggests Feb. 19 in Baltimore. Stakeholders contend that the claims used to set the 2004 rates are flawed, since none of the 27 single-claims used listed the source and related needle and catheter costs - criteria designating a correctly coded claim (1"The Gray Sheet" Nov. 10, 2003, p. 6). CMS says it will attempt to use more multiple claims in time for the 2005 update...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019810

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel